Poland· PL-100015040
Clopixol-Acuphase
A zuclopenthixol product containing zuclopenthixoli acetas, registered in Poland by H. Lundbeck A/S. The same ATC class is registered in 14 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Zuclopenthixol is registered in 14 of 19 countries.
Countries holding a registration under ATC N05AF05 (zuclopenthixol), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Zuclopenthixol · ATC N05AF05
14 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
Price per daily dose
What a daily dose of zuclopenthixol costs, country by country.
Normalised to the WHO defined daily dose (30 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Zuclopenthixol · price per daily dose (30 mg)
USD · FX 28 Sept 2026
- CH Switzerland$1.27
The record
At a glance
URPL (Poland)- Active substance
- Zuclopenthixoli acetas
- Manufacturer
- H. Lundbeck A/S
- Country
- Poland (PL)
- ATC code
- N05AF05
- ATC class
- Zuclopenthixol
- Defined daily dose
- 30 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990126910
- gtin05909990126927
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
70 interactions on record for zuclopenthixol.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Zuclopenthixol · interactions on record
70 records
70 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Zuclopenthixol in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United KingdomClopixol Acuphase 100mg/2ml solution for injection ampoulesLundbeck Ltd
- NetherlandsCisordinol 10 mg, filmomhulde tablettenEuro Registratie Collectief B.V.
- SwedenCisordinol 10 mg Filmdragerad tablettH. Lundbeck A/S
- CzechiaCISORDINOLH. Lundbeck A/S, Valby
- SpainCLOPIXOL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULALundbeck Espana S.A.
- FinlandCisordinolH. Lundbeck A/S
- FranceCLOPIXOL 10 mg, comprimé pelliculéLUNDBECK SAS
- SwitzerlandClopixol
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Cisordinol, Cisordinol Acutard
- Belgium · Clopixol, Clopixol Acutard
- Bulgaria · Клопиксол, Клопиксол-Акюфейз
- Czechia · Cisordinol, Cisordinol-Acutard
- Germany · Ciatyl-Z, Ciatyl-Z Acuphase
- Denmark · Cisordinol, Cisordinol-Acutard
- Estonia · Cisordinol, Cisordinol-Acutard
- Spain · Clopixol, Clopixol Acufase
- Finland · Cisordinol, Cisordinol-Acutard
- France · Clopixol, Clopixol A Action Semi-Prolongee
- United Kingdom (Northern Ireland) · Clopixol, Clopixol-Acuphase
- Greece · Clopixol, Clopixol Acutard
- Hungary · Cisordinol, Cisordinol-Acutard
- Ireland · Clopixol
- Iceland · Cisordinol, Cisordinol-Acutard
- Italy · Clopixol
- Lithuania · Cisordinol, Cisordinol-Acutard
- Luxembourg · Clopixol, Clopixol Acutard
- Latvia · Cisordinol, Cisordinol-Acutard
- Netherlands · Cisordinol, Cisordinol-Acutard
- Norway · Cisordinol, Cisordinol-Acutard
- Portugal · Cisordinol Acutard
- Romania · Clopixol
- Sweden · Cisordinol, Cisordinol-Acutard
- Slovenia · Clopixol, Clopixol-Acuphase
- Slovakia · Cisordinol
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5ed9153f-0920-4bc8-8dab-be4553179233 GET /v1/drugs/5ed9153f-0920-4bc8-8dab-be4553179233?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Roztwór do wstrzykiwań",
"source": "urpl",
"strength": "50 mg",
"packaging": "05909990126910 ¦ Lz ¦ Skasowane ¦ 2590\n1 amp. 1 ml\n05909990126927 ¦ Lz ¦ 2592\n5 amp. 1 ml",
"substance": "Zuclopenthixoli acetas 50 mg",
"common_name": "Zuclopenthixoli acetas",
"pl_product_id": "100015040",
"pozwolenie_nr": "01269",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about zuclopenthixol.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.